Trade PYPD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
PolyPid Ltd. (PYPD) is trading at US$5.39, up 2.28% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$103.59M. Over the past 52 weeks, PYPD has traded between US$3.06 and US$5.73. On Syfe you can trade PYPD with $0 commission and add it to your watchlist.
| Previous close | US$5.27 |
|---|---|
| Market cap | US$103.59M |
| 52-week range | US$3.06 – US$5.73 |
| Volume | 73.1K |
| Exchange | US |
Add to Watchlist
Set Price Alert
PolyPid Ltd.
PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.
Year: 2020
PolyPid Completes Rolling NDA Submission to FDA for D-PLEX100
Jun 1, 1:47 PM · MT Newswires
PolyPid Ltd. (PYPD) stock is trading at US$5.39, +2.28% from the previous close of US$5.27.
The market cap for PolyPid Ltd. (PYPD) stock is approximately US$103.59M.
The 52-week high for PolyPid Ltd. (PYPD) stock is US$5.73.
The 52-week low for PolyPid Ltd. (PYPD) stock is US$3.06.
PolyPid Ltd. (PYPD) does not currently pay a dividend.
Stay on top of PYPD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
